|
|
NYC biotechnology firms have found homes in
the Audubon Biomedical Science and Technology Park.
|
|
Access the Resources
The Giuliani Administration
Sets Biotechnology Goals
New York City's 46 medical schools and major research and 64 hospitals and medical
centers, provide unlimited partnership potential between academia and industry. New York City institutions
and companies also rank second among U.S. cities in National Institutes of Health funding.
The Mayor recently asserted his commitment to making NYC the premier location for medical research by
supporting such projects as The New York City Cancer Project and The New York Structural Biology Center.
In addition, the City is working to implement recommendations of of The Mayor's Biomedical Task Force on
Biomedical Research and Development that aim to grow the presence of the industry in the City, including
the creation of affordable commercial and incubator lab space.
To encourage the growth of the biotechnology industry in New York City, the Mayor proposed a major new
apprenticeship program that will link high school students to medical researchers across the city. The
program will give students the opportunity to learn about science and its applications. In addition, a
high school is being developed to train students in medical research and innovation.
The following are just some of the resources created specifically to aid NYC's biotechnology and
biomedical companies' growth and well-being:
The Audubon Biomedical Science and Technology Park
The New York Biotechnology Association (NYBA)
The Academic Medicine Development Company (AMDeC)
The Council on Biomedical Research and Development
The Biomedical Research Alliance of New York (BRANY)
Recent research projects taking place in NYC include:
The New York City Cancer Project
The New York Structural Biology Center
Much of NYC's recent growth has come about as a result of initiatives established by Mayor Rudolph W.
Giuliani to help businesses grow. Here are a few programs that can take your business to the next level:
Access Funding Sources: If you need capital for
current operations or expansion, our loan programs may meet your needs. If you intend to
manufacture products, you may be able to access tax-exempt bonds to fund capital purchases.
Reduce Energy Costs: Cut electricity and natural
gas costs through various programs available to qualified commercial and industrial businesses.
Seek Venture Capital: The Emerging Industries Fund is a $25 million fund created to address
the pressing need in New York City for early stage financing of small, fast-growing New York
City-based technology-based companies. Eligible companies include technology-based industries,
such as biotechnology, located in or moving into New York City. The New York City Discovery
Fund is a public-private equity investment fund that invests in growing New York City-based
businesses engaged in the development, production, commercialization and use of a wide range
of advanced technologies.
Reduce Taxes: If you are planning to purchase or
rent property and undertake improvements, real estate tax reductions may be available. Companies
intending to purchase facilities may also be able to receive mortgage recording tax and sales tax
savings.
Plug into Digital NYChigh-tech districts
To find out how your company can access New York City's resources, please e-mail us, or call us
toll-free: (877) NYC-4BIO, or (212) 312-3600.
Resources:
The Audubon Biomedical Science and
Technology Park of Columbia University houses both start-up and
established biomedical research firms in NYC. Forty percent of leasable lab space is reserved for
incubator firms at below market rates: from $30 to $35 per-square-foot.
The New York Biotechnology Association (NYBA) assists companies in applying for Small Business Innovation
Research Grants, and administers the New York City Biotechnology Initiative, which helps foster
relationships between industry and academic labs.
The Academic Medicine Development Company (AMDeC), is an organization that comprises 34 leading medical
schools and hospitals in the New York area that work together to help identify sources of capital funding
to support start-ups in the biomedical industry.
The Council on Biomedical Research and Development, established by The New York Academy of Medicine in
1995, is a consortium of health science centers and biotechnology interests addressing the issues affecting
the biomedical research environment in the State of New York.
The Biomedical Research Alliance of New York (BRANY), a creation of the Council on Biomedical Research and
Development,is an alliance of six academic medical centers which conduct high quality clinical trials for
the pharmaceutical and biotechnology industries.
The New York City Cancer Project, a 20-year study examining the environmental and genetic causes
of cancer developed and implemented by AMDeQ, will be one of the largest population-based studies in the
nation.
The New York Structural Biology Center, a collaborative venture formed by the New York City Partnership
and nine universities and hospitals, will build a world-class research institution at the City College of
New York (CUNY) campus in Upper Manhattan, which will house the largest and most advanced cluster of
high-field research magnets (MMRs) in the United States.
|
